Stay updated on Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the record is temporarily unavailable.
    Difference
    18%
    Check dated 2026-09-21T20:28:49.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a new site revision label: v3.6.6, replacing the previous v3.6.5. This reflects a software update and does not modify the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-31T17:28:02.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The NIH grant/contract funding line was added to the study's identifiers, indicating U.S. government support for the ADore trial.
    Difference
    0.0%
    Check dated 2026-08-24T19:57:29.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a small backend/software update rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-08-10T12:47:45.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now shows a new site revision number (v3.6.4) replacing the previous v3.6.3. This reflects a deployment update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:30:50.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces the previous v3.6.2 in the study materials, indicating a newer revision of the provided documents.
    Difference
    0.0%
    Check dated 2026-07-05T13:30:03.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.